Aquestive Therapeutics Inc (NAS:AQST)
$ 3.27 0.18 (5.83%) Market Cap: 297.69 Mil Enterprise Value: 220.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Aquestive Therapeutics Inc Conference Call Transcript

Sep 25, 2020 / 10:30PM GMT
Release Date Price: $7.61 (-2.31%)
Operator

Ladies and gentlemen, thank you for your standing by, and welcome to Aquestive Therapeutics conference call. (Operator Instructions)

I would now like to turn the conference over to your first presenter, Ms. Stephanie Carrington, Westwicke Investor Relations. Please go ahead, ma'am.

Stephanie Carrington
ICR, LLC - SVP

Thank you, operator. Good evening and welcome to today's conference call. On today's call, I am joined by Keith Kendall, Chief Executive Officer; Dan Barber, Chief Operating Officer; and John Maxwell, Chief Financial Officer, who are going to provide an overview of the recent business development. In addition, additional members of the Aquestive team will be available for Q&A. In total, we expect today's call to last approximately 60 minutes.

As a reminder, the company's remarks today correspond with the press release that we issued after market close today in a Form 8-K that was filed with the Securities and Exchange Commission, containing prepared responses to anticipated questions during this call and relevant charts to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot